最新消息

MDR: MDCG 2022-12 - Harmonized Administrative Practices and Alternative Technical Solutions until Eudamed is Fully Functional (for IVDR) – August 2022

MDR: MDCG 2022-12 - Harmonized Administrative Practices and Alternative Technical Solutions until Eudamed is Fully Functional (for IVDR) – August 2022

  • 2022-08-31 05:37:18

MDCG 2022-12 provides guidance to Member States and other relevant parties on the application of certain IVDR provisions during the absence of Eudamed. This guidance intends to describe harmonized administrative practices and alternative technical solutions for the exchange of information until Eudamed becomes fully functional.

了解更多
MDR: MDCG 2022-6 - Guidance on Significant Changes Regarding the Transitional Provision under Article 110(3) of the IVDR – June, 2022

MDR: MDCG 2022-6 - Guidance on Significant Changes Regarding the Transitional Provision under Article 110(3) of the IVDR – June, 2022

  • 2022-06-29 02:14:40

MDCG 2022-6 provides clarifications on the concept of ‘significant changes in the design and intended purposes’ under IVDR Article 110(3). It concerns manufacturers of devices that are compliant with Directive 98/79/EC (IVDD) and that are placed on the market or put into service after 26th May 2022 during the transition period.

了解更多